Download Report

Diabetes Research WA Team

‘RESEARCH IS THE KEY TO OUR FUTURE’

Diabetes Research WA would like to thank all those who have supported our endeavours and who by their generosity allow research into the causes, complications and an ultimate cure for diabetes Annual Report to continue. We are deeply appreciative and look forward to informing you of any breakthroughs as they come to hand. Diabetes Research WA relies on funding from non-government sources. We ask that you continue to support us in our research. For more information please visit our website. 2016-2017 Executive Board Chairman – Mr Peter Kerr Vice Chairman – Dr Joey Kaye Honorary Secretary – Mr Mervyn Rothstein Honorary Treasurer – Mrs Janette Lano

Executive Director Ms Sherl Westlund

Board Members Associate Professor Elizabeth Davis Mr Ken Pettit SC Mrs Catherine Broadbent

Co-opted Board Members Mrs Sally Bruce Ms Liz McGrath Mr Brad Russell-Lane Medical AdvisoryAdvisory Panel Dr. JoeyJoey KayeKaye AssocAssociateiate PrProfessorofessor ElizElizabethabeth DDavisavis Dr GerryGerry FeFegangan DrDr SengSeng Khee GanGan Clinical Professor Tim JonesJones

Level 5,5, Ainslie House,House, RPH PrPrecinctecinct 4488 MurrayMurray Street,Street, Perth WAA 6000 PO Box X2213 Perth WAA 6847 T: ++6161 8 92292244 11006006 E:E [email protected]@diabetesresearchwa.com.au diabetesresearchwa.com.auddiabetesresearchwa.com.au

Presented at the Annual General MeetingMeeting 20th October 2017 The Diabetes Research Foundation of Western Australia Incorporated (Trading as Diabetes Research WA)

OFFICE Level 5 Ainslie House Royal Perth Hospital Precinct 48 Murray Street PERTH WA 6000

POSTAL ADDRESS PO Box X2213 PERTH WA 6847

CONTACT Ph: (08) 9224 1006 [email protected] www.diabetesresearchwa.com.au

CONTENTS

ITEM PAGE

Contents 1

The Executive 2

Chairman’s Report 3-4

WA’s Centre for Diabetes Research Update 5-6

Diabetes Research WA Research Grant Report 7

Financial Statements 8-26

Declaration by Members of the Board 27

Auditor’s Report 28

Supporters 30

1 The Diabetes Research Foundation of Western Australia Incorporated (Trading as Diabetes Research WA)

2016 - 2017 Executive Board & Staff

Executive

Chairman Mr Peter Kerr Vice Chairman Dr Joey Kaye Secretary Mr Mervyn Rothstein Treasurer Mrs Janette Lano

Board Members Mrs Catherine Broadbent Associate Professor Elizabeth Davis Mr Ken Pettit SC

Co-opted Board Members Mrs Sally Bruce Ms Liz McGrath Mr Brad Russell-Lane

Executive Director Ms Sherl Westlund

Executive Assistant Mrs Dione Coleman

Medical Advisory Panel

Chairman Dr Joey Kaye

Members Associate Professor Elizabeth Davis Dr Gerard Chew Dr Gerry Fegan Dr Seng Khee Gan Clinical Professor Tim Jones

Auditor Optima Audit Pty Ltd

Honorary Solicitors Rothstein Lawyers

Patron Her Excellency the Honourable Kerry Sanderson AC, Governor of Western Australia

2 The Diabetes Research Foundation of Western Australia Incorporated (Trading as Diabetes Research WA) 2016-2017 Chairman’s Report

During the 2016/17 financial year, Diabetes Research WA continued to cement its place as an established Western Australian focused research organisation with its key objectives being to:

• investigate the causes and complications of all forms of diabetes; • search for new ways to prevent and control diabetes; and • discover a cure for diabetes.

The volunteer Board and small dedicated staff of the organisation worked extensively with numerous generous supporters to facilitate the continued funding of a number of important diabetes related research projects as well as to expand the fundraising profile of the organisation.

Board Renewal

Following significant personal efforts into the organisation over a combined period in excess of 40 years, we saw the retirement of two long-standing Board members. Firstly, Mr William (Bill) Coleman AM retired from the Board earlier in the year following an involvement which encompassed numerous volunteer positions over the life of the organisation from its formative years. Secondly, Dr Erica Smyth retired as our long-standing Chairman after active involvement since the late 1990s including the last ten years in the Chairman role. Through Erica’s leadership over this time, Diabetes Research WA became the recipient of generous donations and bequests enabling the funding of over 20 research projects into diabetes and diabetes-related matters as well as ongoing funding contributions to our sister institution The Centre for Diabetes Research. Both Bill and Erica leave behind a terrific legacy and we are grateful that they have offered to be called upon by the existing Board members in advisory capacities if required.

In line with these changes, we welcomed a number of new appointments to the Board. Ms Liz McGrath and Ms Sally Bruce joined us bringing their skills in media and legal matters respectively. In addition, Mr Brad Russell-Lane and Mrs Janette Lano have also recently joined bringing important finance and business skills, with Janette taking on the role of Honorary Treasurer.

Research Projects

The 2015 research grants moved into their second year, being Dr Shelley Gorman’s study into “Sunlight, nitric oxide, obesity and type-2 diabetes: exploring the role of brown adipose tissue”, and Professor Grant Morahan’s study into “Predicting which people with diabetes are at high risk for heart disease”.

In November 2016, two new $80,000 research projects were awarded, the first to Assistant Professor Vance Mathews for the “Role of the sympathetic nervous system in regulation of the sodium glucose co- transporter 2: implications of type 2 diabetes” and the second to Dr Karen Rothacker for a study on “The effect of hyperglycaemia in standard and low insulin states on exercise performance compared to exercise performance in euglycemia”. We are grateful for the medical and research specialists who offered their time in assessing the various grant applications we received, this being a challenging job.

Commentary regarding these research projects is contained elsewhere in this Annual Report. Importantly, scientific papers regarding research projects funded by previous grants from Diabetes

3 Research WA have been published in scientific journals, and the profile of our organisation is growing as a result.

Support and Fundraising Activities

Diabetes Research WA continues to be a beneficiary of extremely generous donations, in terms of time and financial support, from various suppliers and supporters. These include Two Moons Consulting which provides extensive pro-bono marketing consulting advice including our vibrant branding profile and website, and Elfin Database Solutions which has dramatically improved our member and marketing database capabilities. Ms Natalie Caudle of Capture Media has also worked tirelessly through the year to successfully increase our media profile in state and local news media, and expand our profile across broader research-based news coverage. Our various Ambassadors, including sports commentator Dennis Cometti, Australian actress Jenni Baird, our Junior Ambassadors Sophie Anti and Ajay McCarthy and Business Ambassador the Western Australian Road Transport Association, have all provided great support and profile to our research funding efforts. We are also grateful for support from many other volunteers including the micro-volunteering team from the University of Western Australia and Royal Perth Hospital which provides office space and support.

Key fundraising activities during the year included:

• The annual Convicts for a Cause event at Old Fremantle Gaol, raising approximately $16,000. This brings to an end our agreed three-year involvement with this volunteer organisation, for which we are very grateful; • Generous donations from a number of Lions Club groups throughout Western Australia, including the Albany Lions Club “Hope in a Boat” project; • A very generous bequest from a supporter not previously known to Diabetes Research WA for approximately $157,000; • Numerous donations from one-off and regular “Be Extraordinary, Give Regularly” donors, including community sports clubs and rural community groups; and • The receipt of modest interest income on our cash reserves.

The Board has formed a Fundraising Committee which focuses at regular meetings on the organisation’s fundraising efforts and longer-term planning, linked with our key research objectives.

Thank You

And finally, the Board of Diabetes Research WA sincerely thanks our research grant recipients and our staff, specifically Ms Sherl Westlund and Mrs Dione Coleman, as well as all of our volunteers, supporters, donors and suppliers for their terrific efforts, energy and support over the last year. This is integral to our organisation.

We look forward to the coming year with a keen focus on our diabetes research projects and expanding our funding capacity to achieve our broader research objectives, in particular the search for an ultimate cure for diabetes.

Peter Kerr Chairman Diabetes Research WA

4 WA Centre for Diabetes Research (The WA Centre for Diabetes Research was established in 2005 through an initiative of the Diabetes Research Foundation WA, The University of Western Australia and WAIMR/Perkins Inst.)

2016 – 2017 Research Update

The beginning of 2017 has seen the start of the movement of the world’s largest next-generation genetic resource, The Gene Mine, to China’s leading animal sciences institute and medical school, Peking Union Medical College in Beijing. We have formed a collaboration with them to host The Gene Mine, as we can no longer afford to keep it here in Australia. I have spent much time helping them to set up their breeding program and various computer databases. I have also been appointed a Joint Professor in Beijing to supervise discovery programs of The Gene Mine in China. This is an excellent opportunity to foster many international collaborations with various research groups in China.

During 2016, The Centre for Diabetes Research joined with a large team of researchers from around Australia to examine the environmental factors that contribute to type 1 diabetes (T1D), and how these interact with the genetic factors we have investigated over the past ten years. This large project, termed ENDIA, is part of the NHMRC-JDRF Centre of Research Excellence for the Protection of Pancreatic Beta Cells, on which I am a Principal Investigator. ENDIA is investigating many different factors, of which we are looking at the genes of the participating child and their family member with T1D. So far in 2017, we have extracted DNA from over 1,000 study members and of these we have genotyped almost half of the infant-proband pairs. We have determined their HLA-DR genotypes using the simplified genetic test we developed. Within the next month, we will start fully genotyping these infant-proband pairs at the 50+ T1D-associated genes.

This year has also seen two international scholars visiting the Centre for Diabetes Research. Firstly, we had PhD student Zafar Iqbal from Quaid Azam University in Pakistan. During his visit here, Mr Iqbal worked on looking at various chemical compounds and whether these compounds could be used to successfully reduce the occurrence of diabetic retinopathy in mouse models. Mr Iqbal showed some interesting results in his experiments and we look forward to mouse collaboration work with him in the future. Our second visiting scholar, undergraduate student Aditya Gangwal from the Indian Institute of Technology, worked toward parallelization of a computationally intensive module that is part of a program which identifies genes associated with complex traits coming from the Gene Mine. He was able to create a robust, user-friendly tool that will make the output of research much easier and faster. Three of our own PhD students, Farhana Ruma, Lakshini Herat and Abraham John will be submitting their theses over the coming months, the final exciting step of the beginning of their research careers.

Another exciting project we have begun this year is looking into the genetics of a large family affected by T1D. We were approached by a person who had T1D, along with various family members spread over four generations. This is highly unusual and the potential cause of their diabetes causes great distress to this family. Genotyping of both the affected and unaffected family members followed by statistical analysis of the results revealed genetic variants that the T1D affected members all share. This is some very exciting new work and we look forward to sharing with you updates on the progress of this research.

On a sad note, after over seven years with the Centre, our Bioinformatics Analyst Dr Ramesh Ram has moved onto another position. In his time here, Dr Ram made many contributions to our research and will be missed. Dr Sylvia Young continues to work on our important Bioinformatics research, which will be explored in depth in our upcoming detailed Annual Report.

5 We also continue to apply our methods to understand better the genetic basis for both T1D and T2D, diabetes complications, and a range of other diseases including dementia, heart disease and melanoma.

Once again, we are grateful to Diabetes Research WA for their support, which is so important in helping us continue with our ground-breaking research.

Professor Grant Morahan Director WA Centre for Diabetes Research

Research projects within the WA Centre for Diabetes Research

Identifying Genetic and Environmental Causes of Type 1 Diabetes: The ENDIA Study Systems Genetics of T1D Maturation of differentiated islet precursor cells toward functional beta cells for better diabetes therapies Identification of rapid and slow progressors to T1D Genetic signatures of age onset for T1D patients using T1DGC dataset Gene Identification Tools for Use with Gene Mine Mice Strains Using the Gene Mine to Find Genes that Protect Against Dementia Variability of Retinal Blood Vessels in the Gene Mine Genetic Variation in the Number of Immune Cells Genetic Control of Immune Dendritic Cell Populations Genetic Regulation of Insulin Production Beta Cell Redifferentiation: a potential mechanism to improve functionality Investigation of Rare Mutations within a Family on Diabetes Susceptibility

The WA Centre for Diabetes Research Team

Director Professor Grant Morahan

Bioinformatics Research Fellow Dr Sylvia Young Senior Research Officer Dr Lois Balmer Research Associate Dr Kevin Li

Administration & Research Officer Bek Brittain

Research Assistant Quang Nguyen PhD Students Farhana Ruma Abraham John

Undergraduate Assistant Grainne Cahill

2017 Visiting Scholars Zafar Iqbal Aditya Gangwal

6 The Diabetes Research Foundation of Western Australia Incorporated (Trading as Diabetes Research WA)

2016-2017 Research Grant Report

The 2016/17 year was another exciting and successful year for diabetes research in Western Australia, particularly involving those researchers and projects supported by DRWA.

As in recent years, two project grants were awarded by DRWA for research conducted primarily in WA. Grant applications were divided between basic/fundamental science and clinical/translational science. Each grant application is reviewed and assessed by several independent clinicians and basic science research peers working in the diabetes field in Western Australia. All the assessors were again highly impressed by, and noted, the very high quality of each grant application.

The basic/fundamental science grant for 2016 was awarded to Assistant Professor Vance Matthews from The University of Western Australia for a project examining the role of the sympathetic nervous system and a new class of medication (SGLT-2 (sodium/glucose like transporter 2) inhibitors) in reducing cardiovascular disease in people with type 2 diabetes.

Dr Karen Rothaker, in collaboration with the team from Princess Margaret Hospital and the UWA School of Sport Science, was awarded the clinical/translation grant to investigate the prevalence and mechanisms behind the development of hypoglycaemia (low glucose levels) and performance during exercise in people with type 1 diabetes.

Previously supported studies are also drawing to completion with Dr Shelley Gorman from the Telethon Kids Institute reporting that her team have successfully developed a transgenic mouse model, which they will use to continue to examine the role of sunlight on brown adipose tissue and the subsequent impact on nitric oxide generation, which has the potential to modify future obesity and type-2 diabetes development.

Dr Gerard Hoyne from Notre Dame University, Fremantle, has completed his studies looking at the role of the immune CDK4 cell in regulating beta cell homeostasis and function. His studies have demonstrated the presence of these cells in an animal model of type 1 diabetes and have also demonstrated their role in beta-cell survival and insulin secretion. The results have been presented at local and national meetings and formal publication is anticipated shortly.

Dr Aron Chakera from The Harry Perkins Institute of Medical Research has completed his trial of the use of linagliptin (an oral diabetes therapy) in the development and management of diabetes occurring after kidney transplantation. His study has demonstrated that the treatment is safe and effective at maintaining glucose levels and may also improve insulin sensitivity, thereby potentially reducing the risk of post-transplant diabetes. These results have also been presented nationally and internationally.

Dr Joey Kaye Chairman Diabetes Research WA Medical Advisory Panel

The Diabetes Research Foundation of Western Australia (Inc.) ABN 43743957408

Trading as Diabetes Research WA

Annual Financial Report For the year ended 30 June 2017

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

TABLE OF CONTENTS

BOARD REPORT ...... 10 AUDITOR’S INDEPENDENCE DECLARATION ...... 15 FINANCIAL STATEMENTS ...... 15 STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME ...... 17 STATEMENT OF FINANCIAL POSITION ...... 18 STATEMENT OF CASH FLOWS ...... 19 STATEMENT OF CHANGES IN ACCUMULATED FUNDS ...... 20 NOTES TO THE FINANCIAL STATEMENTS ...... 21 1. GENERAL INFORMATION AND STATEMENT OF COMPLIANCE ...... 21 2. CHANGES IN ACCOUNTING POLICIES ...... 21 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ...... 21 4. REVENUE ...... 24 5. EXPENSES ...... 24 6. CASH AND CASH EQUIVALENTS ...... 24 7. TRADE AND OTHER RECEIVABLES ...... 24 8. OTHER FINANCIAL ASSETS ...... 24 9. EQUIPMENT ...... 25 10. TRADE AND OTHER PAYABLES ...... 25 11. EMPLOYEE BENEFITS ...... 25 12. EVENTS AFTER THE BALANCE SHEET DATE ...... 26 13. RELATED PARTY TRANSACTIONS ...... 26 14. COMMITMENTS ...... 26 15. CONTINGENT LIABILITY ...... 26 DECLARATION BY MEMBERS OF THE BOARD ...... 27 AUDITOR’S OPINION ...... 28

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

BOARD REPORT

The Members of the Board present their Report together with the financial report of The Diabetes Research Foundation of Western Australia (Inc.) (“the Association” or “DRFWA”) for the year ended 30 June 2017 and the auditor’s report thereon.

MEMBERS OF THE BOARD

Mr Peter Kerr Chairman of the Board since May 2017 Peter is an Australian Chartered Accountant with more than 20 years’ experience in the mining industry in Australia and Canada, including corporate, operations and senior executive roles. He is presently Chief Financial Officer at Mount Gibson Iron Limited. Having been part of DRFWA’s Board from 1997 to 2000 and greatly admiring the work of the organisation over a long period, Peter re- joined DRFWA in October 2015. Peter was appointed Chairman in May 2017 and is passionate about research into all forms of diabetes.

Dr Joey Kaye Vice-Chairman Joey is a Consultant Endocrinologist and the Director of Diabetes Services at Sir Charles Gairdner Hospital in Western Australia. Joey completed his undergraduate medical training at The University of Western Australia, physician training at various hospitals in Western Australia and completed specialist training in Endocrinology and Diabetes in 2001. Joey undertook a PhD in neuro- endocrinology at the University of Bristol in the UK from 2000-03.

Mr Mervyn Rothstein Honorary Secretary Mervyn is a commercial lawyer and registered migration agent who has had involvement in various diabetes associations in Australia and South Africa for over 30 years.

Mrs Janette Lano Honorary Treasurer Janette is a highly experienced group accountant at Perseus Mining Limited and prior to this worked at Mount Gibson Iron Limited. She joined the DRFWA Board in May 2017 as Honorary Treasurer. Janette is a member of CPA Australia and understands the power of research to make a difference to the lives of those with the condition.

Associate Professor Elizabeth Davis Board Member Liz is a Paediatric Endocrinologist and Deputy Head of the Department of Diabetes and Endocrinology at Princess Margaret Hospital in Perth, WA. She is also a Senior Clinical Lecturer at the Telethon Institute for Child Health Research. Liz works as a clinician and is actively involved in research relating to diabetes, obesity and the metabolic syndrome in children.

Mr Ken Pettit SC Board Member Ken is a Senior Counsel and commenced practise at the Independent Bar in 1995. Ken has practised in large commercial matters, administrative and constitutional law, public sector inquiries and investigations, industrial law and native title litigation.

Mrs Catherine Broadbent Board Member Cathy is a Principal Accountant and tax advisor who spent more than 20 years at PricewaterhouseCoopers and is a member of the Salary and Allowances Tribunal. She has a personal interest in diabetes and helping to progress the search for a cure.

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

BOARD REPORT - continued

MEMBERS OF THE BOARD - continued

Ms Sally Bruce Co-opted Board Member Sally has over 18 years’ experience in estate litigation and succession planning and holds the position of Special Counsel at Jackson McDonald. Estate litigation is a major part of Sally’s practice. She has acted in many family provision disputes and strives to achieve cost effective mediated outcomes wherever possible.

Ms Liz McGrath Co-opted Board Member Liz is a writer and communicator with more than 25 years’ experience working in Australia, London and New York, and is the Media Advisor and Uniview Editor at The University of Western Australia.

Mr Brad Russell-Lane Co-opted Board Member Brad holds the role of CEO North West Shelf & Vice President Australia Business at Woodside Energy where he has worked since 1989. Brad is also a committee member at Southern Capes Motorcycle Club. He was diagnosed with Type 1 diabetes at the age of 36 and is an advocate for workplace and corporate giving, believing that diabetes research in WA is world-class.

Dr Erica Smyth Past Chairman of the Board, resigned May 2017 With a Master of Science degree in Minerals Exploration, Erica has enjoyed a long career in the minerals and petroleum industries and is now a professional company director. She is an independent director of Emeco Holdings Ltd, ANSTO, the Deep Exploration Technologies CRC and the Royal Flying Doctor Service (Western Operations). Erica, who has Type 1 diabetes, has been with DRFWA since 1998. Erica resigned from the Board in May 2017 and remains a committed supporter of the organisation.

EXECUTIVE MANAGEMENT

Ms Sherl Westlund Executive Director Sherl joined DRFWA in 1997 after returning to Perth from a stint in the country as the Clinical Co-ordinator of the Northampton Asthma Service and Resource/Education Officer for the Asthma Foundation in the Midwest. Sherl is passionate about diabetes research and the benefits for all that this can bring, from improved quality of care for those living with diabetes to easier methods of insulin administration and the real possibility of finding a cure. Sherl is an Associate Fellow of the Australian Institute of Management, a member of the Australian Institute of Company Directors and a member of the Australasian Society for Association Executives.

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

BOARD REPORT - continued

MEETINGS OF MEMBERS OF THE BOARD

The number of meetings of the Association’s Members of the Board held during the year ended 30 June 2017, and the numbers of meetings attended by each member of the Board were:

Members of the Board Board Fundraising Meetings Committee Meetings A B A B Mr Peter Kerr 3 3 4 4 Dr Joey Kaye 3 - - - Mr Mervyn Rothstein 3 3 - - Mrs Janette Lano - - 1 - Ms Sherl Westlund 3 2 4 4 Associate Professor Elizabeth Davis 3 2 - - Mr Ken Pettit SC 3 2 - - Mrs Catherine Broadbent 3 2 4 4 Ms Sally Bruce 2 2 4 4 Mr William Coleman 1 1 4 4 Ms Liz McGrath 2 2 4 2 Mr Brad Russell-Lane - - 1 1 Dr Erica Smyth 3 3 - -

A = Number of meetings eligible to attend B = Number of meetings attended

PRINCIPAL ACTIVITIES

The principal activity of the Association during the year was to act as a charitable institution providing research funds to Western Australian diabetes researchers. No significant change in the nature of those activities occurred during the year.

DIVIDENDS

As the Association has no share capital, no dividends are payable.

REVIEW OF OPERATIONS

DRFWA is a private charitable Association dedicated to the funding of research in Western Australia focused on the prevention, control and cure of all types of diabetes. The Association’s objectives are to fund the State’s best researchers to investigate the causes and complications of all forms of diabetes, to search for new ways to prevent and control diabetes, and to discover a cure for diabetes. Funds are sourced from bequests, fundraising initiatives, workplace and corporate giving, and generous personal donations.

KEY STRATEGIES FOR ACHIEVING OBJECTIVES

Through the Association’s efforts, funds are sourced for the purpose of enabling world-class diabetes research in Western Australia. The Association currently awards two annual research grants to applicants through a formal and competitive application process. The selection of grant awardees each year is overseen by an independent Medical Advisory Panel. This panel reviews all grant applications and makes recommendations to the Members of the Board on the worthiness of such applications. Approval of research grants is ultimately decided by the Board.

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

BOARD REPORT - continued

MEASUREMENT OF PERFORMANCE

The success of DRFWA is measured through formal and informal monitoring of our key objectives for each year. The Board meets approximately every two months and at each meeting reviews the financial, marketing and research outcomes of the Association, and its future plans. The key areas monitored include:

• Compliance with regulatory and acceptable business practices; • Effective management of the Association; • Cost control; • Periodic fundraising targets; • Applications and processes for the award of research grants; • Website “hits” and enquiries, and media presence; and • Performance of fundraising and other programs against expectations.

SIGNIFICANT CHANGES IN STATE OF AFFAIRS

During the year, the Association continued to raise funds from generous estate bequests and donations from members and other individuals and companies, and to apply these funds to diabetes research projects and general running costs. In addition, as foreshadowed last year, DRFWA returned the sum of $295,980 to a deceased estate at the request of the relevant estate executor following further interpretation of the deceased’s bequest documentation.

Other than the above, there were no significant changes in the state of affairs during the financial year.

MATTERS SUBSEQUENT TO THE END OF THE FINANCIAL YEAR

No other matters or circumstances have arisen since 30 June 2017 that have significantly affected the Association’s operations, results or state of affairs, or may do so in future years.

ENVIRONMENTAL REGULATION

The Association’s operations are not subject to any significant environmental regulations under either Commonwealth or State Legislation.

INDEMNIFICATION AND INSURANCE OF OFFICERS AND AUDITORS

Since the start of this financial year, the Association has not indemnified or made a relevant agreement for indemnifying against a liability for any person who is or has been an officer or auditor of the Association.

During the financial year the Association has paid premiums in respect of Members of the Board and Officers’ liability and legal expenses insurance contracts for the year ending 30 June 2017. Such insurance contracts insure against liability (subject to specific exclusions) arising against persons who are or have been Members of the Board or Officers of the Association.

BOARD MEMBERS’ BENEFITS

During the year no member of the Board has received or become entitled to receive any benefit by reason of a contract made by the Association with the member of the Board or with a firm of which he or she is a member or a company in which he or she has a substantial financial interest, except as otherwise disclosed in Note 12 of the financial statements.

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

BOARD REPORT - continued

GRANTS PAID AND AWARDED

In financial year 2016-17, the Association paid grants (excluding GST) totalling $119,798 (2015-16: $75,000) as listed below:

2016-17 2015-16 $ $ Centre for Diabetes Research – G Morahan - 37,500 Telethon Kids Institute – S Gorman 37,500 37,500 Princess Margaret Hospital – K Rothacker 40,000 - University of Western Australia – V Matthews 40,000 - Matt Cooper – travel grant 2,298 - 119,798 75,000

To ensure that the Association is kept updated and across any issues with the research, DRFWA releases half of the funds first upon receipt of an invoice and the remainder is released midway through the research following receipt of a suitable interim report.

AUDITOR’S INDEPENDENCE DECLARATION

A copy of the Auditor’s Independence Declaration as required under section 60.40 of the Australian Charities and Not-for-profits Commission Act 2012 (ACNC) is set out on page 15 and forms part of this Board Report.

This Board Report is made in accordance with a resolution of the Members of the Board.

Peter Kerr Chairman of the Board

Janette Lano Honorary Treasurer

Perth 11 September 2017

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

AUDITOR’S INDEPENDENCE DECLARATION

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

FINANCIAL STATEMENTS

This financial report covers The Diabetes Research Foundation of Western Australia (Inc.), trading as “Diabetes Research WA” (the “Association” or “DRFWA”) as an individual entity.

The financial report is presented in Australian currency.

DRFWA is a not-for-profit association incorporated in Western Australia under the Associations Incorporation Act (WA) 2015 (‘the Act’). Its registered office and the principal place of business is:

Level 5 Ainslie House RPH Precinct 48 Murray Street Perth WA 6000

A description of the nature of the Association’s operations and its principal activities is included in the Board Report on pages 10–14, which does not form part of these financial statements.

The financial statements were authorised for issue by the Members of the Board on 11September 2017. The Members of the Board have the power to amend and reissue the financial statements.

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT

STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE YEAR ENDED 30 JUNE 2017

Year Ended Year Ended 30 June 30 June Notes 2017 2016 $ $

Revenue from continuing operations 4 252,904 427,014

Expenses Employee benefits expenses (160,719) (159,912) Advertising and promotion (62,107) (53,156) Bequest Returned 5 (295,980) - Other expenses 5 (20,052) (24,204) Research grants expensed during the year (119,798) (150,000) Surplus (deficit) for the year (405,752) 39,742

Other comprehensive income for the year - - Items that will not be reclassified subsequently to profit or loss - - Items that may be reclassified to profit or loss - - Other comprehensive surplus (deficit) for the year - -

Total comprehensive income (deficit) for the year (405,752) 39,742

The above statement of profit or loss and other comprehensive income should be read in conjunction with the accompanying notes.

17 The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT

STATEMENT OF FINANCIAL POSITION AS AT 30 JUNE 2017

30 June 30 June Notes 2017 2016 $ $

ASSETS Current assets Cash and cash equivalents 6 1,072,975 1,540,880 Trade and other receivables 7 6,527 16,622 Other assets 8 1,990 1,476 Total current assets 1,081,492 1,558,978

Non-current assets Equipment 9 1,235 488 Total non-current assets 1,235 488

TOTAL ASSETS 1,082,727 1,559.466

LIABILITIES Current liabilities Trade and other payables 10 58,039 102,040 Employee benefits 11 9,848 36,833 Total current liabilities 67,887 138,874

TOTAL LIABILITIES 67,887 138,874

NET ASSETS 1,014,840 1,420,592

ACCUMULATED FUNDS Retained Earnings 1,014,840 1,420,592

TOTAL ACCUMULATED FUNDS 1,014,840 1,420,592

The above statement of financial position should be read in conjunction with the accompanying notes.

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 30 JUNE 2017

Year Ended Year Ended 30 June 30 June Notes 2017 2016 $ $

Cash flows from operating activities Donations received 225,158 363,034 Bequest returned 5 (298,980) - Interest received 29,758 42,145 Memberships 611 531 Other income 281 25,911 Payment to suppliers and employees (303,654) (230,710) Research and education expenses (119,798) (150,000) Net cash flows from operating activities (466,624) 50,911

Cash flows used in investing activities Receipts from/(Investments into) Term Deposits - 1,268,537 Acquisition of office equipment (1,281) - Net cash flows from investing activities (1,281) 1,268,537

Net increase/(decrease) in cash and cash equivalents (467,905) 1,319,448 Cash and cash equivalents at beginning of period 1,540,880 221,432 Cash and cash equivalents at end of period 6 1,072,975 1,540,880

The above statement of cash flows should be read in conjunction with the accompanying notes.

The Diabetes Research Foundation of Western Australia (Inc.) ANNUAL REPORT For the year ended 30 June 2017

STATEMENT OF CHANGES IN ACCUMULATED FUNDS FOR THE YEAR ENDED 30 JUNE 2017

General Total Accumulated Funds Funds $ $

Balance at 1 July 2015 1,380,850 1,380,850 Surplus (Deficit) for the year 39,742 39,742 Other comprehensive income - - Balance at 30 June 2016 1,420,592 1,420,592

Balance at 1 July 2016 1,420,592 1,420,592 Surplus/(Deficit) for the year (405,752) (405,752) Other comprehensive income - - Balance at 30 June 2017 1,014,840 1,014,840

The above statement of changes in accumulated funds should be read in conjunction with the accompanying notes.

NOTES TO THE FINANCIAL STATEMENTS 30 June 2017

1. GENERAL INFORMATION AND STATEMENT OF COMPLIANCE

The financial report includes the financial statements and notes of The Diabetes Research Foundation of Western Australia (Inc.).

These general purpose financial statements have been prepared in accordance with Australian Accounting Standards – Reduced Disclosure Requirements. The Diabetes Research Foundation of Western Australia (Inc.) is a not-for-profit entity for the purpose of preparing the financial statements.

The financial statements for the year ended 30 June 2017 were approved and authorised for issue by the Members of the Board on 11 September 2017.

2. CHANGES IN ACCOUNTING POLICIES

None of the new standards and amendments to standards that are mandatory for the first time for the financial year beginning 1 July 2016 affected any of the amounts recognised in the current period or any prior period and are not likely to affect future periods.

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The significant accounting policies that have been used in the preparation of these financial statements are summarised below.

The financial statements have been prepared using the measurement bases specified by Australian Accounting Standards for each type of asset, liability, income and expense. The measurement bases are more fully described in the accounting polices below.

3.1 Basis of Preparation

First-time adoption of IFRS accounting policy These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). These financial statements for the year ended 30 June 2017 are the first the Association has prepared in accordance with IFRS.

Historical cost convention These financial statements have been prepared on a going concern basis and under the historical cost convention.

Critical accounting estimates Preparation of financial statements in conformity with Australian Accounting Standards requires the use of certain critical accounting estimates. It also requires management to exercise judgement in the process of applying the Association’s accounting policies. There were no areas involving higher degrees of judgement or complexity, or areas where assumptions and estimates were significant to the financial statements of the Association.

Functional and presentation currency Items included in the financial statements of the Association’s operations are measured using the currency of the primary economic environment in which the entity operates (‘the function currency’). The financial statements are presented in Australian dollars, which is the Association’s functional and presentation currency.

NOTES TO THE FINANCIAL STATEMENTS 30 June 2017 (continued)

3.2 Revenue Recognition

Revenue is measured by reference to the fair value of consideration received or receivable, when the Association is legally entitled to the income and the amount can be quantified with reasonable accuracy.

Donations Donations are recognised when the amounts are received. In common with most organisations dependent on such contributions, the Association is unable to establish control over voluntary donations prior to their initial entry into the accounting records.

Bequests Revenue is recognised when bequests are received by the Association.

Interest Revenue Interest Revenue is recognised on a time proportionate basis that takes into account the effective yield on the financial asset.

3.3 Property, Plant and Equipment

Property, plant and equipment is stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by the Association.

Where a bequest is received in the form of assets, these are recognised at fair value at the date acquired.

Depreciation is recognised on a straight-line basis to write down the cost less estimated residual value of the asset. The estimated useful lives range as follows:

Buildings 25 to 50 years Vehicles 4 to 10 years IT Equipment 3 to 5 years Furniture, fittings and other equipment 3 to 8 years

The assets’ residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined as the difference between the disposal proceeds and the carrying amount of the assets and are recognised in profit or loss within other income or other expenses.

3.4 Income Tax

The Diabetes Research Foundation of Western Australia (Inc.) is exempt from tax under Subdivision 50-B of the Income Tax Assessments Act 1997.

NOTES TO THE FINANCIAL STATEMENTS 30 June 2017 (continued)

3.5 Cash and Cash Equivalents

Cash and cash equivalents include cash at bank and other short term highly liquid investments with original maturities of three months or less.

For the purposes of presentation in the Statement of Cash Flows, cash and cash equivalents consist of cash and cash equivalents as defined above. Cash flows are presented in the Statement of Cash Flows on a gross basis.

3.6 Payables

These amounts represent liabilities for goods and services provided to the Association prior to the end of the financial year which are still outstanding. The amounts are unsecured and are usually paid within 30 days of recognition. Trade and other payables are presented as current liabilities unless payment is not due within 12 months from the reporting date. They are recognised initially at their fair value.

3.7 Employee benefits

The liability for employee benefits relates to amounts expected to be paid to employees for annual leave, long service leave, salary sacrifice and superannuation. It is based on legal and contractual entitlements. Current wage rates are used in the calculation of the provision.

3.8 Goods and Services Tax (GST)

Revenues, expenses and assets are recognised net of the amount of GST, except where the amount of GST incurred is not recoverable from the Australian Taxation Office. In these circumstances the GST is recognised as part of the cost of acquisition of the asset or as part of an item of the expense. Receivables and payables in the statement of financial position are shown inclusive of GST.

Cash flows are presented in the statement of cash flows on a gross basis, except for the GST components of investing and financing activities, which are disclosed as operating cash flows.

3.9 Contingent Liabilities

Where there exists a possible obligation, defined as having a less than a 50% chance of becoming a present obligation, the Association recognises a contingent liability.

3.10 Adoption of new and revised accounting standards

The Association has adopted all standards which become effective for the first time at 30 June 2017, the adoption of these standards has not caused any material adjustments to the reported financial position, performance or cash flow of the Association.

3.11 New accounting standards and interpretations

The AASB has issued new and amended Accounting Standards and Interpretations that have mandatory application dates for future reporting periods. The Association has decided not to early adopt these Standards.

NOTES TO THE FINANCIAL STATEMENTS 30 JUNE 2017 (continued)

30 June 30 June 2017 2016 $ $ 4. REVENUE

General donations 64,339 61,701 Bequests from deceased estates 156,620 301,333 Memberships 670 590 Interest 29,679 37,436 Other Income 1,596 25,954 252,904 427,014

5. EXPENSES

Bequest Returned Repayment of bequest income received in FY2015-16 295,980 -

Other Expenses Audit fees 1,800 2,250 Legal fees 41 5,425 Insurance 2,352 1,558 Depreciation 533 213 Other administration costs 15,326 14,759 20,052 24,205

6. CASH AND CASH EQUIVALENTS

For the purposes of the Cash Flow Statement, cash and cash equivalents comprise the following at 30 June: Cheque accounts 65,901 164,461 Term deposit 1,007,074 1,375,419 1,072,975 1,540,880

7. TRADE AND OTHER RECEIVABLES

Receivables 1,980 1,980 Net GST receivable 2,570 14,635 Interest receivable 1,977 7 6,527 16,622

8. OTHER ASSETS

Prepayments 1,990 1,476 1,990 1,476

NOTES TO THE FINANCIAL STATEMENTS 30 JUNE 2017 (continued)

9. EQUIPMENT

Gross carrying amount Furniture and IT Equipment Total Fixtures Balance 1 July 2016 2,804 - 2,804 Additions - 1,281 1,281 Disposals - - - Revaluation - - - Balance 30 June 2017 2,804 1,281 4,085

Accumulated Depreciation Furniture and IT Equipment Total Fixtures Balance 1 July 2016 2,316 - 2,316 Additions 214 320 533 Disposals - - - Revaluation - - - Balance 30 June 2017 2,530 320 2,849

Carrying Amount Furniture and IT Equipment Total Fixtures At 1 July 2016 488 - 488 At 30 June 2017 274 961 1,235

10. TRADE AND OTHER PAYABLES 30 June 30 June 2017 2016 $ $

Accrued expenses 47,165 90,972 PAYG withholding payable 7,170 7,408 Superannuation payable 3,704 3,660 58,039 102,040

11. EMPLOYEE BENEFITS

Liability for annual leave 9,848 23,083 Liability for long service leave - 13,750 9,848 36,833

NOTES TO THE FINANCIAL STATEMENTS 30 JUNE 2017 (continued)

12. EVENTS AFTER THE BALANCE SHEET DATE

No adjusting or significant non-adjusting events have occurred between the reporting date and the date of authorisation.

13. RELATED PARTY TRANSACTIONS

The Association’s related parties include its Key management personnel and related entities as described below.

Unless otherwise stated, none of the transactions incorporate special terms and conditions and no guarantees were given or received.

Transactions with Key management personnel Key management of the Association are the Members of the Board and the Executive Director. Details of the Members of the Board are disclosed in the Board Report. Other than the Executive Director who received remuneration, the other Members of the Board of DRFWA did not receive any emoluments during the year. No Members of the Board are associated with companies or firms which provided services to the Association during the year.

14. COMMITMENTS

The Association has the following diabetes research commitments as at 30 June 2017:

• Remaining amount of $40,000 payable for the study on the effect of hypoglycaemia in standard and low insulin states on exercise performance; and • Remaining amount of $40,000 payable for the study on the role of the sympathetic nervous system in regulation of sodium glucose co-transporter 2.

15. CONTINGENT LIABILITY

There are no contingent liabilities that have been incurred by the Association in relation to the financial year ended 30 June 2017.

DECLARATION BY MEMBERS OF THE BOARD

In the opinion of the Members of the Board of The Diabetes Research Foundation of Western Australia (Inc.):

The financial statements and notes of The Diabetes Research Foundation of Western Australia (Inc.) are in accordance with the Australian Charities and Not-for-profits Commission Act 2012, including:

i. Giving a true and fair view of its financial position as at 30 June 2017 and of its performance for the financial year ended on that date; and ii. Complying with Australian Accounting Standards – Reduced Disclosure Requirements (including the Australian Accounting Interpretations)

There are reasonable grounds to believe that The Diabetes Research Foundation of Western Australia (Inc.) will be able to pay its debts as and when they become due and payable.

Signed in accordance with a resolution of the Members of the Board.

Chairman – Mr Peter Kerr

Treasurer – Mrs Janette Lano

Dated: 11 September 2017

The Diabetes Research Foundation of Western Australia (Inc) registered company auditors Independent Audit Report to the members of The Diabetes Research Foundation of Western Australia (Inc)

Report on the Audit of the Financial Report

Qualified Opinion

We have audited the financial report of Diabetes Research Foundation of Western Australia (Inc) (the Entity), which comprises the statement of financial position as at 30 June 2017, the statement of profit and loss and comprehensive income, the statement of changes in equity and the statement of cash flows for the year ended, and notes to the financial statements, including a summary of significant accounting policies, and the declaration by those charged with governance.

In our opinion, except for the effects of the matter described in the Basis for Qualified Opinion section of our report, the accompanying financial report presents fairly, in all material respects, including:

(i) giving a true and fair view of the Entity's financial position as at 30 June 2017 and of its financial performance and its cash flows for the year ended; and

(ii) complying with Australian Accounting Standards - Reduced Disclosure Regime.

Basis for Qualified Opinion

It is not always practicable for the Entity to establish accounting controls over all sources of fundraising appeal activities prior to receipt of these funds by employees of the Entity and accordingly it is not possible for our examination to include procedures which extend beyond the amounts of such income recorded in the accounting records of the Entity.

We conducted our audit in accordance with Australian Auditing Standards. Our responsibilities under those standards are further described as in the Auditor's Responsibilities for the Audit of the Financial Report section of our report. We are independent of the Entity in accordance with the auditor independence requirements of the ethical requirements of the Accounting Professional and Ethical Standards Board's APES 110 Code of Ethics for Professional Accountants (the code) that are relevant to our audit of the financial report in Australia. We have also fulfilled our other ethical responsibilities in accordance with the Code.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.

Emphasis of Matter - Basis of Accounting

Without modifying our opinion, we draw attention to Note 1 to the financial report which describes the basis of accounting. The financial report is prepared to assist The Diabetes Research Foundation of WA (Inc) to report to its members. As a result, the financial report may not be suitable for another purpose.

Responsibilities of Management and Those Charged with Governance

Management is responsible for the preparation and fair presentation of the financial report in accordance with Australian Accounting Standards, and for such internal control as the management determines is necessary to enable the preparation of the financial report is free from material misstatement, whether due to fraud or error.

In preparing the financial report, management is responsible for assessing the Entity's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Entity or to cease operations, or has no realistic alternative but to do so.

Those charged with governance are responsible for overseeing the Entity's financial reporting process.

43 158 633 615 optima audit pty ltd acn 158 633 615 Auditor's Responsibilities for the Audit of the Financial Report

Our objectives are to obtain reasonable assurance about whether the financial report as a whole is free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Australian Auditing Standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of this financial report.

Optima Audit

Michael Cooper Osborne Park 11 September 2017 Our Key Supporters during the 2016/2017 Financial Year

The corporate and community support we receive at Diabetes Research WA is critital to our success. This comprises donations, memberships, sponsorship, professional services, discounted rates for services and products we need, volunteering, fundraising and/or helping us raise awareness of what we do and why.

Allied Pumps Mrs Audrey Frank Mr Peter Leong Mr Raymond Raeburn L Ambrosini Fred Mafrica - The Couch Mr Neil Leslie Mrs Marion Reid Ms Sophie Anti & Family Dr Seng Khee Gan Mr John Lewis Mr Andrej Renko Mr John Baines Mr Stephen Gardner Lions Club of Albany - Hope in a Boat Ms Gillian Renton-Lees Ms Jenni Baird Mr Ian Garrett Lions Club of Anglesea Dr Richard Reynolds Ms Samantha Baker Ms Maree Gardner Lions Club of Australind Mr Peter Richards Mr James Barron Ms Lorraine Gates Lions Club of Ballajura Rohan Jewellers Ms Pam Bassford Mr John Gaunt Lions Club of Brunswick Mullumbimby Mr Mervyn Rothstein Dr Terry Bayliss Ms Sally Gaunt Lions Club of Dalwallinu & Districts Royal Perth Hospital Ms Carolina Benavatto Gebauer Family Lions Club of East Fremantle Mr Brad Russell-Lane Mrs Frances Bentley Mrs Marie Gelle Lions Club of Hannan's Goldfields Mrs Patsy Russell-Lane Mr Digby Blight AO Goldvision Bookeeping Services Lions Club of Robe and District Swagelok WA Mr Kevin Bogue Dr Janie Goh Mrs Leta Liwszyc Miss Chloe Shaw Mrs Wendy Bourne Goldfields Golf Club Ms Alamein Lowry Mrs Linda Shipster Ms Jodi Brauer Mrs Ellen Gooding Mr Steve McDonagh Shopnate Ms Onika Brewer Mr Albert Gough Ms Josephine McEwen Mrs Kim Siew Loo Mrs Catherine Broadbent Mr & Mrs F Granger Ms Joanne Manning Mr & Mrs I Skipworth Mrs Joyce Brockway Dr Vanessa Guthrie Ms Heather Marland Mr Dominic Smith Mr Don Brooks Mr & Mrs L Guthrey Ms Kate Maxwell Ms Erica Smyth Mrs Sally Bruce GWN7 Ms Tanya Maxwell Mr Ian Spence Mrs P Butler Dr Peter Hales Mr Richard McKenna Dr Rodney Steens Mr & Mrs J Byass Ms Jane Hannaford Professor Barry & Mrs Adrienne Marshall Dr Gary Stein Mr Gordon Calvert Ms Sue Harding Mr Salvatore Martella Mr Malcolm Teale Ms Jennifer Chalmers Harry F Carter Charitable Trust Mrs Margaret Martin Mr Arthur Tantiprasut Mrs Kelva Campbell OAM Mr MJ Harvey Mstr Ajay McCarthy & Family Mr Brian Thompson Capture Media Ms Ranate Haubner Ms Liz McGrath Mr Kevin Trent Mrs Emma Cobby Mr & Mrs P Hiatt Meeting Minds Networking Group Mr John Turner Professor Alex Cohen AO Ms Ann Hobbs Micro Volunteering UWA Two Moons Consulting Mr & Mrs J Coleman Mr Terry Hobson Mrs Nancy Mills Ms Lindy Twycross Mr William Coleman AM Miss Joan Hogan Ms Alison Milner Mr Donald Underdown Community Pod Mrs Janet Holmes a Court AC Mr Linton Mincherton United Way Convicts for a Cause Mrs Cynthia Horne Mrs Isabella (Belle) Moore University of WA Guild Volunteering Ms Halley Cowan Mr Jeffrey How Professor Grant Morahan Mrs Kerry Vincenti Craigie Baptist Church Craft Group Mrs A Howard Ms Dorothy Moles Mr Matthew Warrier CWA Pumphreys Bridge Mr Ian Jepson Mrs Norah Murphy Wesleyana Club Ms Vivienne D'Aloia Mrs Lesley Johnson Ms Hazel Murray Mrs Norma West D'Scribe Professional Writing Services Mr Robert Johnson Mr Peter Myles Western Power Ms Kristy Danzo Mr David Johnston Mr Quang Thien Nguyen Ms Sherl Westlund Associate Professor Elizabeth Davis Mr Geoffrey Jones Mr Robert O'Connor QC Mrs Rebecca Wheatley Mr Ian Donald Professor Tim Jones Mr Ross O'Neil Mr Bryan Whichelo Mr Adam Donkin Mrs Veronica Julien Optima Audit Mr Trevor Williams Mr Richard Dougal Kambalda West District High School Dr Nicol Ormonde Mr John Williamson Mr Jeremy D'Souza Dr Patricia Kailis AM Ms Valerie Overton Mrs Hildegund Wittenberg Mrs Phyllis Edwards Dr Joey Kaye Mr & Mrs C Pearse Woodside Energy Ltd Ms Kerri Eggleston Mr Peter Kerr Mr David Peet Worldwide Printing Solutions Elfin Database Solutions Kore Graphic Design The Stan Perron Charitable Trust Ms Lucia Wright & Family Mrs Alwyn Even Mr & Mrs J Kusmierek Mr Ken Pettit SC Ms Cilla Fahey-Gilmour Mr Simon Ledewig Mr Ray Plowman Dr Gerry Fegan Ms Corin Lamont Mrs Beth Powell Mrs Maureen Felton Ms Jeanette Lamothe Mr John Pritchard Mrs Karen Field Ms Janette Lano Mrs Tania Pullella Mrs Beverley Fitzgerald Dr Christine Lawson-Smith Mr Rushdi Qandour Ms Angela Formato Professor Peter Leedman Mr & Mrs R Radford Mr Ray Foster Mrs Kim Siew Loo Radiowest

30 Diabetes Research WA Team

‘RESEARCH IS THE KEY TO OUR FUTURE’

Executive Director Ms Sherl Westlund

Board Members Associate Professor Elizabeth Davis Mr Ken Pettit SC Mrs Catherine Broadbent

Presented at the Annual General MeetinMeetingg 20th October 2017